This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell short of expectations, results that cast into doubt the future competitiveness of the company in the booming weight loss market. The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at all participants, including those who dropped out, Novo said Friday.
A single digital prescribing record across healthcare settings in England could reduce medication errors by between 10% and 50%, leading to between 18,000 and 913,000 fewer errors, between 3,000 and 15,800 fewer people experiencing harm and saving four to 22 lives annually, researchers have suggested. An integrated system has the potential to save time for […] The post A single digital prescribing record could reduce medication errors 'by between 10% and 50%' appeared first on Th
The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S. Zepbound, whose scientific name is tirzepatide, has now been specifically approved for patients with both obesity and moderate-to-severe obstructive sleep apnea, or OSA, a condition characterized by breathing interruptions during sleep.
Indias life sciences industry continues to demonstrate its stature as a global powerhouse, often referred to as the pharmacy of the world. Renowned for its extensive production of generic drugs and vaccines, the sector has played a pivotal role in addressing global healthcare demands. As of 2024, India has produced nearly half of the eight billion vaccine doses distributed worldwide, cementing its reputation as a reliable healthcare contributor.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do foresee a few developments, such as promenading the official mascots, hanging with one of our short people, and escorting Mrs. Pharmalot to a house party or two.
GPs in England have received a contract offer for the next financial year, starting in April 2025, the government has announced. The government also confirmed this week that negotiations for the current financial year community pharmacy contractual framework, which should have started in April 2024, will not begin until the new year. Paul Rees, chief […] The post BREAKING: Outrage as GPs offered 25/26 contract while pharmacies still waiting for 24/25 appeared first on The Pharmacist.
GPs in England have received a contract offer for the next financial year, starting in April 2025, the government has announced. The government also confirmed this week that negotiations for the current financial year community pharmacy contractual framework, which should have started in April 2024, will not begin until the new year. Paul Rees, chief […] The post BREAKING: Outrage as GPs offered 25/26 contract while pharmacies still waiting for 24/25 appeared first on The Pharmacist.
On Nov. 18, a female pediatric patient participating in a clinical trial suffered a systemic hyperinflammatory syndrome and died about two weeks after receiving a gene therapy. Her death comes as both a setback for GT and a warning about managing future research. It is time to put the sharing of information among research teams ahead of the current prioritization of secrecy for commercial purposes.
Children from the most deprived areas are four times more likely to die from an asthma attack, a charity has warned. Asthma + Lung UK called on the Government to take urgent action to prevent child asthma deaths including tackling poor housing conditions and air pollution. It comes as theNational Child Mortality Database Report on […] The post Latest report on child asthma deaths highlights stark impact of deprivation appeared first on The Pharmacist.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we have the highly anticipated CagriSema results. We also see Ionis win approval for a new drug, which means it will start bringing its commercialization efforts in-house. And the FDA says tirzepatide is no longer in shortage.
As the government offers GPs an additional 889m in a new contract set to start in April 2025, Jay Badenhorst, director of pharmacy at the Pharmacists' Defence Association (PDA), highlights a 'troubling disparity' in support for the community pharmacy sector. While the governments proposed GP reforms and significant funding boost are welcome steps to alleviate […] The post Jay Badenhorst: Disparity between GPs and pharmacy threatens the collaborative nature of integrated care' appeared
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
As we wrap up 2024, Indias life sciences sector is demonstrating unparalleled growth, driven by strategic infrastructure development, government policy support, and a cost-effective talent pool. This year alone, we witnessed the demand for healthcare infrastructure skyrocket, with estimates indicating a need for an additional 1.3 billion square feet of healthcare space by 2030 and 2.9 million hospital beds to meet global standards.
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
For roughly a century, ever since Alexander Fleming's accidental discovery of penicillin in 1928, fungi have proven to be a goldmine for medicines. They've provided treatments for a wide range of diseases, from infections and high cholesterol to organ rejection and even cancer. However, the process by which fungi synthesize some of their most potent compounds remains opaque.
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
In this episode of Drug Digest, industry experts discuss their experiences in dealing with the challenges of developing and manufacturing next-generation biotherapeutics as well as triumphs that move the industry as a whole forward.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest FDA leader to leave the agency, and two biotechs cut research deals.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The findings show a need for researchers and health care professionals to consider model designs to minimize disparities when diagnosing perinatal mood and anxiety disorders (PMADs).
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
345 
Let's personalize your content